Inventor · disambiguated record
Po-Ying Chan-Hui
Also filed as: CHAN-HUI III PO-YING · CHAN-HUI PO-YING
27 granted patents·13 pending applications·525 citations·filing 2003–2025
97Inventor score
Files withTHERACLONE SCIENCES INC14MONOGRAM BIOSCIENCES INC11CHAN-HUI PO-YING4INT AIDS VACCINE INITIATIVE INC2ACLARA BIOSCIENCES INC1
Top patents by PatentIndex Score
40 records- 0196US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0296US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0396US7217531B2Multiplex analysis using membrane-bound sensitizersMONOGRAM BIOSCIENCES·Filed 2005·Granted May 15, 2007·60 cites·6 claims
- 0495US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 0595US7648828B2Methods for detecting receptor complexes comprising PI3KMONOGRAM BIOSCIENCES INC·Filed 2005·Granted Jan 19, 2010·34 cites·13 claims
- 0694US6949347B2Multiplex analysis using membrane-bound sensitizersACLARA BIOSCIENCES INC·Filed 2003·Granted Sep 27, 2005·65 cites·15 claims
- 0793US8247180B2Measuring receptor homodimerizationPIDAPARTHI SAILAJA·Filed 2008·Granted Aug 21, 2012·46 cites·14 claims
- 0892US9051362B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityCHAN-HUI PO-YING·Filed 2010·Granted Jun 9, 2015·14 cites·20 claims
- 0992US7402399B2Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapyMONOGRAM BIOSCIENCES INC·Filed 2004·Granted Jul 22, 2008·75 cites·7 claims
- 1092US7105308B2Detecting receptor oligomerizationMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Sep 12, 2006·55 cites·31 claims
- 1191US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 1291US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 1388US7402397B2Detecting and profiling molecular complexesMONOGRAM BIOSCIENCES INC·Filed 2004·Granted Jul 22, 2008·40 cites·10 claims
- 1488US7135300B2Profiling frequencies of receptor heterodimersMONOGRAM BIOSCIENCES INC·Filed 2004·Granted Nov 14, 2006·34 cites·26 claims
- 1586US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 1686US7402398B2Measuring receptor homodimerizationMONOGRAM BIOSCIENCES INC·Filed 2004·Granted Jul 22, 2008·27 cites·6 claims
- 1786US7122319B2Multiplexed immunohistochemical assays using molecular tagsMONOGRAM BIOSCIENCES INC·Filed 2003·Granted Oct 17, 2006·30 cites·10 claims
- 1885US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 1983US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 2081US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 2179US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 2278US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 2377USRE44437EMethods for detecting receptor complexes comprising PI3KCHAN-HUI PO-YING·Filed 2012·Granted Aug 13, 2013·2 cites·20 claims
- 2476US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 2574US8609101B2Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodiesCHAN-HUI PO-YING·Filed 2010·Granted Dec 17, 2013·3 cites·20 claims
- 2669US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 2760US9920111B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2015·Granted Mar 20, 2018·0 cites·8 claims
- 2856US2004175765A1Cell-screening assay and compositionFiled 2003·Application pending·0 cites
- 2955US2008187948A1Erbb heterodimers as biomarkersMONOGRAM BIOSCIENCES INC·Filed 2007·Application pending·0 cites
- 3055US2009011432A1Detecting and Profiling Molecular ComplexesMONOGRAM BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 3154US2014341923A1Human Rhinovirus (HRV) AntibodiesTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 3254US2009011440A1Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And TherapyMONOGRAM BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 3351US2004229294A1ErbB surface receptor complexes as biomarkersFiled 2004·Application pending·0 cites
- 3450US8822651B2Human rhinovirus (HRV) antibodiesCHAN-HUI PO-YING·Filed 2012·Granted Sep 2, 2014·0 cites·48 claims
- 3550US2004229380A1ErbB heterodimers as biomarkersFiled 2004·Application pending·0 cites
- 3648US2009111127A1Surface Receptor Complexes as BiomarkersMONOGRAM BIOSCIENCES INC·Filed 2007·Application pending·0 cites
- 3746US2004229293A1Surface receptor complexes as biomarkersFiled 2004·Application pending·0 cites
- 3845US2006166282A1Methods and compositions for screening cell binding moleculesSINGH SHARAT·Filed 2003·Application pending·0 cites
- 3944US2014328797A1Human rhinovirus (hrv) antibodiesTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 4039US2010291594A1ErbB Surface Receptor Complexes as BiomarkersLAB CORP AMERICA HOLDINGS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Po-Ying Chan-Hui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →